Dynavax Technologies 新闻与活动
在场
高管
查看带有其 31 名主要高管的组织结构图
Dynavax Technologies 搜索最多的简介
- Ryan Spencer, Chief Executive Officer and Director
- Julie Eastland, Director
- Brent MacGregor, Director
高管在Dynavax Technologies变化
- Justin Burgess, Principal Accounting Officer, 将于 20253月3 退休 (新闻发布的2025二月11号).
- Kelly Macdonald 曾任 Senior Vice President and Chief Financial Officer, 将于 20253月2 现任 Senior Vice President, Chief Financial Officer and Principal Accounting Officer (新闻发布的2025二月10号).
创建提醒
跟踪 Dynavax Technologies 的高管变动
生物技术
Dynavax Technologies 拥有 2,347 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Johnson & Johnson Innovative Medicine DIA (美国(美洲))。
Popular M&A news in 生物技术
- Glycomine 刚刚宣布为 115 筹款数百万美元。 (公布2025四月22号).
- Attovia Therapeutics 刚刚宣布为 90 筹款数百万美元。 (公布2025四月21号).
- Transcarent and Accolade have merged (公布2025四月9号)..
生物技术 行业的其他推荐联系人
消息
Dynavax Technologies 的最新新闻稿
- RSS News Feeds | Dynavax Technologies Corporation
- Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October | Dynavax Technologies Corporation
- Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate | Dynavax Technologies Corporation
- Dynavax Announces Appointment of New Board Member and Planned Retirement of Chief Financial Officer | Dynavax Technologies Corporation
- Press Releases | Dynavax Technologies Corporation
- Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine | Dynavax Technologies Corporation
- Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference | Dynavax Technologies Corporation
- Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Response | Dynavax Technologies Corporation
- Dynavax Announces Second Quarter 2020 Financial Results | Dynavax Technologies Corporation
- TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales | Dynavax Technologies Corporation
- View more press releases Close
